Position in ASND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,066
-$3,737 QoQ
Shares Held
4
-81.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#301
of 307 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $8,088 across 7 Biotechnology names. ASND ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTR |
Nektar Therapeutics
|
56 | $3,909 | |
| 2 | VRDN |
Viridian Therapeutics, Inc.\DE
|
71 | $1,304 | |
| 3 | ASND |
Ascendis Pharma A/S
This page
|
4 | $1,066 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
16 | $908 | |
| 5 | INVA |
Innoviva, Inc.
|
36 | $817 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
3 | $53 | |
| 7 | IMCR |
Immunocore Holdings plc
|
1 | $31 |
All Filings in ASND
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,066 | 4 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,803 | 21 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,875 | 51 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $7,296 | 53 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $895 | 6 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $7,558 | 50 | Shares | Sole | 2025-03-11 | |
| 2023-06-30 | $3,927 | 44 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $7,847 | 76 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,504 | 113 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,229 | 19 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||